Director, Clinical Program Management
Alkermes
Summary
Provide strategic and operational leadership for the planning, management, oversight, and execution of clinical programs in support of Alkermes' R&D portfolio. This role is accountable for advancing programs across the development lifecycle, including lifecycle management (LCM) initiatives and supplemental NDA (sNDA) submissions, with a focus on high-quality, patient-centric execution.
Job description
Responsibilities
- Responsible for planning, oversight and execution of assigned clinical programs: responsible for timelines, budget, and key deliverables as well as contributing to overall clinical strategy
- Participates on Clinical Teams as operational representative, partnering closely with Clinical Science, Biostatistics, Regulatory, Medical Affairs, Translational Medicine, and other functions to shape and execute integrated clinical development plan
- Responsible for project budget/resource planning, re-forecasting, milestone, payment and variance tracking with Clinical Outsourcing & Finance, and Project Management
- Establish and monitor program performance metrics, leveraging data and insights to continuously improve execution and inform leadership decision-making
- Provides strategic input and oversight in development of clinical plans, protocols, SAPs, consent form development, and other program/study related documents
- Works with clinical outsourcing, legal, and finance in the selection of CROs and vendors, and participates in contract and budget negotiations
- Manages relationships and establishes strong partnerships with CROs, vendors, investigators and other external partners to ensure delivery of high-quality, timely outcomes
- Partner with the Study Start-Up team on clinical start-up activities including feasibility, country selection/recommendation, budget & timeline planning, supply chain, and regulatory preparation
- Provides oversight for project-related data integration/technology activities including IVRS, ePRO, central lab, etc along with data management department
- Provides oversight and support to direct reports fostering talent development, performance management, and a culture aligned with Alkermes leadership expectations and values
Qualifications
Basic Qualifications:
- Bachelor's Degree in life sciences or healthcare-related field; Master's Degree preferred
- Minimum of 10 years of clinical development experience in a pharmaceutical/biotech or CRO setting
Preferred Qualifications:
- Proven track record of leading global, complex clinical programs across multiple phases, with deep experience in Phase 4/LCM programs
- Strong leadership presence with the ability to influence and drive alignment across cross-functional teams
- Excellent strategic thinking, organizational, and execution skills with the ability to manage competing priorities
- Strong knowledge and understanding of GCP/ICH Guidelines and regulatory requirements
Physical Demands and Work Environment:
- Ability to travel domestically and internationally (up to 20%)
Requirements
- Bachelor's Degree in life sciences or healthcare-related field
- Minimum of 10 years of clinical development experience in a pharmaceutical/biotech or CRO setting
- Master's Degree preferred
- Proven track record of leading global, complex clinical programs across multiple phases
- Deep experience in Phase 4/LCM programs
- Strong leadership presence with ability to influence and drive alignment across cross-functional teams
- Excellent strategic thinking, organizational, and execution skills
- Strong knowledge and understanding of GCP/ICH Guidelines and regulatory requirements
- Ability to travel domestically and internationally (up to 20%)
Benefits
- Annual performance bonus
- Competitive benefits package
- Hybrid work model
Company overview
Alkermes plc is a global biopharmaceutical company specializing in neuroscience-focused medicines for psychiatric and neurological disorders. Founded in 1987 and headquartered in Dublin, Ireland, the company maintains a significant research and development center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Alkermes has established itself as a leader in developing treatments for complex conditions including schizophrenia, bipolar I disorder, alcohol dependence, and opioid dependence. The company's portfolio includes proprietary commercial products such as Lybalvi (olanzapine/samidorphan), Aristada (aripiprazole lauroxil), and Vivitrol (naltrexone), alongside a robust pipeline of clinical and preclinical candidates targeting neurological disorders like narcolepsy and idiopathic hypersomnia. With approximately 1,800-2,100 employees worldwide, Alkermes combines deep neuroscience expertise with sophisticated development capabilities to address traditionally overlooked or stigmatized conditions, maintaining a patient-centered approach to drug development and commercialization.